Good Morning frosr6,
Thanks for sharing that DD. It was a very good read and details much.
Since yesterday, we have started a debate over who got the FDA approval - PMCB or The University of Northern Colorado. To me this is a mute point. The fact is clear that the university (under the leadership of Dr. Hyslop) applied for the license last October. It is clearly spelled out to use cannabis in testing using the Cell in a Box delivery system. PMCB owns the rights to CiaB. I seriously doubt that the university will suddenly abandon their studies and dump PMCB. They applied for, and received, this elusive license to test our delivery system of cannabinoids. No one will convince me that the DEA hands out these licenses like candy, or that they did not vet every detail of the application. This vetting no doubt included very extensive digging into PMCB.
Late last year PMCB received ODD from The FDA in their studies against pancreatic cancer. Many here made it seem trivial at best. We have now received DEA approval for our studies against multiple cancers. I have no doubt that some will attempt to trivialize this milestone as well.
Anyone seeing what this great company is accomplishing cannot help but be thrilled. We are systematically advancing our studies across the globe against diabetes and many cancers. Yesterday has validated that PMCB is a very legitimate biotech company with potential like none that I have ever seen.
I will end this by thanking Kenneth Waggoner for the outstanding job that he is doing.
Keep up the great work Mr. Waggoner,
Bill
News 
Market Data 
Discover 
